A method to assess the dissipation of residual hypnotics: Eszopiclone versus zopiclone

Journal of Clinical Psychopharmacology

Volumn 32, Issue 5, 2012, Pages 704-709

  Boyle, Julia ^a   Groeger, John A ^b,c   Paska, Walter ^d   Cooper, James A ^d   Rockett, Carol ^e   Jones, Sion ^d   Gandhi, Paul ^d   Scott, Jenny ^d   Atzori, Giuseppe ^a   Dijk, Derk Jan ^a,b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d GLAXOSMITHKLINE   (United Kingdom)

^e GLAXOSMITHKLINE   (United States)

Author keywords

eszopiclone; hypnotic; insomnia; sleep inertia; zopiclone

Indexed keywords

ESZOPICLONE; PLACEBO; ZOPICLONE;

ADULT; AROUSAL; ARTICLE; ATTENTION DISTURBANCE; COGNITION; CONTROLLED STUDY; CRITICAL FLICKER FUSION; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DYSGEUSIA; EVENING DOSAGE; FATIGUE; FEMALE; HALLUCINATION; HUMAN; MALE; NAUSEA; NIGHTMARE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SINGLE DRUG DOSE; SLEEP; SLEEP DEPRIVATION; SOMNOLENCE;

ADULT; AZABICYCLO COMPOUNDS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; NEUROPSYCHOLOGICAL TESTS; PIPERAZINES; PSYCHOMOTOR PERFORMANCE; TIME FACTORS;

EID: 84865862846     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182664eec     Document Type: Article

References (22)

1. Zisapel N. Insomnia: principles and management. BMJ. 2004;328:55.
2. Daley M, Morin CM, LeBlanc M, et al. Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents. Sleep Med. 2009;10:427-438.
3. Ohayon MM. Insomnia: a ticking clock for depression? J Psychiatric Res. 2007;41:893-894.
4. Staner L Comorbidity of insomnia and depression. Sleep Med Rev. 2010;14:35-46.
5. Vermeeren A, Riedel WJ, van Boxtel MPJ, et al. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with low dose alcohol. Sleep. 2002;25:224-231.
6. Vermeeren A Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs. 2004;18:297-328.
7. Verster JC, Volkerts ER, Olivier B, et al. Zolpidem and traffic safety: the importance of treatment compliance. Curr Drug Saf. 2007;2:220-226.
8. Rosenberg R, Caron J, Roth T, et al. An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults. Sleep Med. 2005;6:15-22.
9. Najib J. Eszopiclone, a non benzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia. Clin Ther. 2006;28:491-516.
10. Boyle J, Trick L, Johnsen S, et al. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone. Hum Psychopharmacol. 2008;23:385-397.
11. Erman MK, Zammit G, Rubens R, et al. A polysomnography placebocontrolled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. J Clin Sleep Med. 2008;4:229-234.
12. Groeger JA., Zijlstra FR, Dijk DJ. Sleep quantity, sleep difficulties and their perceived consequences in a representative sample of some 2000 British adults. J Sleep Res. 2004;13:359-371.
13. Jewett ME,Wyatt JK, Ritz-de Cecco A, et al. Time course of sleep inertia dissipation in human performance and alertness. J Sleep Res. 1999;8:1-8.
14. Parkin C, Fairweather DB, Shamsi Z, et al. The effects of cigarette smoking on overnight performance. Psychopharmacology. 1998;136:172-178.
15. Woodworth R, Schlosberg H. Experimental Psychology. London, UK: Methuen; 1954.
16. Wechsler D.Wechsler Adult Intelligence Scale Y Revised. New York, NY: The Psychological Corporation; 1981.
17. Groeger JA, Viola AU, Lo JC, et al. Early morning executive functioning during sleep deprivation is compromised by a PERIOD3 polymorphism. Sleep. 2008;31:1159-1167.
18. Hindmarch I, Patat A, Stanley N, et al. Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening. Hum Psychopharmacol Clin Exp. 2001;1:159-167.
19. European Medicines Agency (EMAEA). London, UK; 2006. Available at: http://www.emea.eu.int. Accessed August 25, 2011.
20. Gustavsen I, Bramness JG, Skurtveit S, et al. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med. 2008;9:818-822.
21. Fava M, McCall WV, Krystal A, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry. 2006;59:1052-1060.
22. Shekleton JA, Rogers NL, Rajaratnam MW. Searching for the daytime impairments of primary insomnia. Sleep Med Rev. 2010;14:47-60.